VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $150,000 | -99.2% | 31,800 | -98.8% | 0.00% | -99.1% |
| Q4 2020 | $19,391,000 | -33.0% | 2,712,083 | 0.0% | 0.22% | -44.5% |
| Q3 2020 | $28,938,000 | -15.5% | 2,712,083 | 0.0% | 0.40% | -17.4% |
| Q2 2020 | $34,226,000 | +37.3% | 2,712,083 | -0.4% | 0.48% | +0.2% |
| Q1 2020 | $24,926,000 | -33.9% | 2,724,083 | +0.7% | 0.48% | -19.2% |
| Q4 2019 | $37,725,000 | -19.0% | 2,704,283 | -0.0% | 0.60% | -30.9% |
| Q3 2019 | $46,548,000 | -36.2% | 2,704,683 | +0.9% | 0.87% | -30.5% |
| Q2 2019 | $72,957,000 | +27746.2% | 2,680,283 | +9506.7% | 1.25% | +7229.4% |
| Q4 2018 | $262,000 | -68.1% | 27,900 | -35.7% | 0.02% | -67.3% |
| Q3 2018 | $822,000 | +148.3% | 43,422 | +156.6% | 0.05% | +85.7% |
| Q2 2018 | $331,000 | – | 16,922 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |